Bingqi Tong
ORCID: 0009-0005-9139-4328Also affiliated with Novartis (Switzerland), Harvard University, Harvard University Press, United Therapeutics (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 8 papers. Top paper: “Targeted Protein Degradation via a Covalent Reversible Degrader Based on Bardoxolone”.
Mai Luo, Yi Xie, Jessica N. Spradlin, John A. Tallarico, Jeffrey M. McKenna +4 more
Paulo A. Machicao, Bingqi Tong, Emily Ho, Julia Friedli, Brian So +5 more
Mai Luo, Yi Xie, Jessica N. Spradlin, John A. Tallarico, Jeffrey M. McKenna +4 more
Bridget P. Belcher, Daniel K. Nomura, Thomas J. Maimone, Bingqi Tong
Paulo A. Machicao, Bingqi Tong, Emily Ho, Julia Friedli, Brian So +5 more
Mai Luo, Yi Xie, Jessica N. Spradlin, John A. Tallarico, Jeffrey M. McKenna +4 more
Joel K.A. Adade, Xiebin Gu, Cody Hecht, Michael Salcius, Bingqi Tong +7 more
Jessica N. Spradlin, Luiz F. T. Novaes, Erika Zhang, Xirui Hu, Malte Moeller +8 more